Azalea Therapeutics

Notes

Azalea Therapeutics is a recently launched biotechnology company focused on developing transformative therapeutics for patients with serious diseases. As one of the newest portfolio companies from Third Rock Ventures, one of the leading life sciences venture capital firms, Azalea benefits from significant scientific expertise and resources.

The company is building its pipeline and scientific platform with the goal of advancing novel drug candidates into clinical development.

Team

• Leadership team and scientific founders information not yet publicly disclosed

Additional Research Findings

• Portfolio company of Third Rock Ventures
• One of Third Rock's newest company launches
• Focus on therapeutics development for serious diseases
• Boston biotech ecosystem location
• Early-stage company building pipeline
• Access to Third Rock's extensive scientific network

Sources

• Azalea Therapeutics Official Website
• Third Rock Ventures Portfolio